Skip to main content
Premium Trial:

Request an Annual Quote

Affy and CureSearch Children s Oncology Group to Research Gene-Expression Signatures

NEW YORK, Oct. 25 (GenomeWeb News) - Affymetrix and CureSearch Children's Oncology Group will jointly research gene-expression signatures for childhood cancers, Affymetrix said today.


Affymetrix will use its GeneChip microarray technology for this effort. COG has an existing databank of more than 20,000 tumor samples.


COG scientists will use Affymetrix microarrays to find similarly expressed genes amongst a group of children sharing the same disease. The identified genetic fingerprint will allow physicians to test other patients for common pediatric cancers, including leukemia and sarcoma.


Additional details were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.